Shihchen Kuo, Ph.D.
Affiliations: | 2013 | Epidemiology | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Epidemiology, General Economics, Health Care Management, Military StudiesGoogle:
"Shihchen Kuo"Parents
Sign in to add mentorJanice C. Zgibor | grad student | 2013 | University of Pittsburgh | |
(Cost-effectiveness of implementing the interventions for diabetes prevention and control in the community and military settings.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Su HY, Yang CY, Chang YH, et al. (2025) Within-trial cost-effectiveness of novel macrophage-regulating treatment on wound healing in patients with diabetic foot ulcers. Journal of Food and Drug Analysis. 33: 21-30 |
Herman WH, Kuo S, Zhang P. (2024) A comment on "Metformin in the Diabetes Prevention Program 3-year trial: The cost-effectiveness that never was". Diabetes, Obesity & Metabolism |
Kuo S, Ye W, Wang D, et al. (2024) Cost-Effectiveness of the National Diabetes Prevention Program: A Real-World, 2-Year Prospective Study. Diabetes Care |
Su HY, Nguyen TTD, Lin WH, et al. (2024) External validation and calibration of risk equations for prediction of diabetic kidney diseases among patients with type 2 diabetes in Taiwan. Cardiovascular Diabetology. 23: 357 |
Gonzalez JS, Bebu I, Krause-Steinrauf H, et al. (2024) Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): A Randomized Clinical Trial. Diabetes Care |
Cherrington AL, Tripputi MT, Younes N, et al. (2024) Impact of Glucose-Lowering Medications on Health-Related Quality of Life in Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care |
Sun H, Saeedi P, Karuranga S, et al. (2023) Erratum to "IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045" [Diabetes Res. Clin. Pract. 183 (2022) 109119]. Diabetes Research and Clinical Practice. 110945 |
Pihoker C, Braffett BH, Songer TJ, et al. (2023) Diabetes Care Barriers, Use, and Health Outcomes in Younger Adults With Type 1 and Type 2 Diabetes. Jama Network Open. 6: e2312147 |
Yang CT, Yao WY, Ou HT, et al. (2023) Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: a model-based cost-effectiveness analysis using real-world data. Diabetes Research and Clinical Practice. 110625 |
Su HY, Yang CY, Ou HT, et al. (2023) Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective. Jama Network Open. 6: e2250639 |